Abstract
Objective Harnessing drug-related data posted on social media in real time can offer insights into how the pandemic impacts drug use and monitor misinformation. This study developed a natural language processing (NLP) pipeline tailored for the analysis of social media discourse on COVID-19 related drugs.
Methods This study constructed a full pipeline for COVID-19 related drug tweet analysis, utilizing pre-trained language model-based NLP techniques as the backbone. This pipeline is architecturally composed of four core modules: named entity recognition (NER) and normalization to identify medical entities from relevant tweets and standardize them to uniform medication names, target sentiment analysis (TSA) to reveal sentiment polarities associated with the entities, topic modeling to understand underlying themes discussed by the population, and drug network analysis to potential adverse drug reactions (ADR) and drug-drug interactions (DDI). The pipeline was deployed to analyze tweets related to COVID-19 and drug therapies between February 1, 2020, and April 30, 2022.
Results From a dataset comprising 2,124,757 relevant tweets sourced from 1,800,372 unique users, our NER model identified the top five most-discussed drugs: Ivermectin, Hydroxychloroquine, Remdesivir, Zinc, and Vitamin D. Sentiment and topic analysis revealed that public perception was predominantly shaped by celebrity endorsements, media hotspots, and governmental directives rather than empirical evidence of drug efficacy. Co-occurrence matrices and complex network analysis further identified emerging patterns of DDI and ADR that could be critical for public health surveillance like better safeguarding public safety in medicines use.
Conclusion This study evidences that an NLP-based pipeline can be a robust tool for large-scale public health monitoring and can offer valuable supplementary data for traditional epidemiological studies concerning DDI and ADR. The framework presented here aspires to serve as a cornerstone for future social media-based public health analytics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Added relevant References, added more introduction and discussion
Data Availability
Data, source code, and pipeline tutorial of this paper are available at https://github.com/zju-liwanxin/covid-twitter-drug.
